Patient Attitudes Toward DTC Advertising
Revisiting Aspects of the 2004 Landmark FDA Study
Biopharmaceutical spend on DTC continues to grow, even in the face of negative statements from leadership in government, the medical community, and patient advocacy. What do patients think about advertising for prescription drugs? What channels would patients prefer to use when looking for health information?
In November 2004, the FDA released a final report on the findings of a study that explored patient and physician perspectives on DTC advertising as it relates to the healthcare experience. Our current research asks more than 500 consumers a subset of the questions originally fielded by the FDA to determine how attitudes have changed over the last decade. Analysis also examines current consumer preferences for program types and communication channels to assist marketers in choosing the best options for their target audiences.
|Quantitative Report – Overall Findings||45 pp, Powerpoint format||$6,500|
|Quantitative Report – Comparing the Chronically Ill vs the Occasionally Ill||30 pp, Powerpoint format||$2,500|
|Infographics||Now and Then Snapshot
Patient Program & Channel Preferences
|Quantitative Data Tables||Banner 1: Gender, Age, Race
Banner 2: Condition
Banner 3: Insurance Status, Treatment Segment
After you complete and submit the form below, we will contact you when the reports are available to arrange payment. Please note the reports you would like to order in the message box. All products are delivered electronically and can be printed upon receipt.